• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在阿尔茨海默病中,Meynert核内胆碱乙酰转移酶活性的大量丧失并未表现为神经元的丢失。

Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.

作者信息

Perry R H, Candy J M, Perry E K, Irving D, Blessed G, Fairbairn A F, Tomlinson B E

出版信息

Neurosci Lett. 1982 Dec 13;33(3):311-5. doi: 10.1016/0304-3940(82)90391-3.

DOI:10.1016/0304-3940(82)90391-3
PMID:7162693
Abstract

Choline acetyltransferase activity in discrete tissue punches from the nucleus of Meynert and in tissue from the temporal cortex was reduced by at least 90% and 75%, respectively, in 5 out of 6 elderly cases of Alzheimer's disease compared with 5 normal cases. In contrast, estimates of neurone density in these same cases revealed that there was only, on average, a 33% neurone loss in the nucleus of Meynert in Alzheimer's disease. These observations suggest that a key pathological change in Alzheimer's disease may be the 'down regulation' of transmitter-specific enzyme production in cholinergic neurones, and that neurone loss itself may be a secondary feature of the disease.

摘要

与5例正常病例相比,在6例老年阿尔茨海默病患者中,有5例来自迈内特核的离散组织切片以及颞叶皮质组织中的胆碱乙酰转移酶活性分别降低了至少90%和75%。相比之下,对这些相同病例的神经元密度估计显示,在阿尔茨海默病中,迈内特核平均仅有33%的神经元丢失。这些观察结果表明,阿尔茨海默病的一个关键病理变化可能是胆碱能神经元中递质特异性酶产生的“下调”,并且神经元丢失本身可能是该疾病的一个次要特征。

相似文献

1
Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.在阿尔茨海默病中,Meynert核内胆碱乙酰转移酶活性的大量丧失并未表现为神经元的丢失。
Neurosci Lett. 1982 Dec 13;33(3):311-5. doi: 10.1016/0304-3940(82)90391-3.
2
The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.阿尔茨海默病中的无名质:胆碱能标记酶的组织化学和生物化学研究
Neurosci Lett. 1982 Feb 12;28(2):217-22. doi: 10.1016/0304-3940(82)90155-0.
3
Is the loss of cerebral cortical choline acetyl transferase activity in Alzheimer's disease due to degeneration of ascending cholinergic nerve cells.阿尔茨海默病中大脑皮质胆碱乙酰转移酶活性的丧失是由于上行胆碱能神经细胞的退化所致吗?
J Neurol Neurosurg Psychiatry. 1982 Oct;45(10):936. doi: 10.1136/jnnp.45.10.936.
4
Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.阿尔茨海默病。皮质胆碱乙酰转移酶活性与痴呆严重程度及组织学异常的相关性。
J Neurol Sci. 1982 Dec;57(2-3):407-17. doi: 10.1016/0022-510x(82)90045-4.
5
Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.帕金森病认知障碍的胆碱能相关性:与阿尔茨海默病的比较。
J Neurol Neurosurg Psychiatry. 1985 May;48(5):413-21. doi: 10.1136/jnnp.48.5.413.
6
Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease.晚期阿尔茨海默病中的基底核神经元丢失、神经炎性斑块及胆碱乙酰转移酶活性
Neuroscience. 1986 Dec;19(4):1279-91. doi: 10.1016/0306-4522(86)90142-9.
7
Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.阿尔茨海默病和帕金森病中Meynert核的病理变化。
J Neurol Sci. 1983 May;59(2):277-89. doi: 10.1016/0022-510x(83)90045-x.
8
Cholinergic deficit in frontal cerebral cortex in Alzheimer's disease is age dependent.阿尔茨海默病患者额叶皮质中的胆碱能缺陷与年龄相关。
Lancet. 1981;2(8260-61):1422. doi: 10.1016/s0140-6736(81)92836-1.
9
Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.阿尔茨海默病患者及对照者大脑中胆碱乙酰转移酶免疫组化研究
Neurosci Lett. 1983 Apr 11;36(2):195-9. doi: 10.1016/0304-3940(83)90264-1.
10
Alzheimer's disease and the new neuroscience.阿尔茨海默病与新神经科学
Biol Psychiatry. 1983 Aug;18(8):847-8.

引用本文的文献

1
Heterologous expressing melittin in a probiotic yeast to evaluate its function for promoting NSC-34 regeneration.在益生菌酵母中异源表达蜂毒素,评估其促进 NSC-34 再生的功能。
Appl Microbiol Biotechnol. 2024 Oct 28;108(1):496. doi: 10.1007/s00253-024-13336-7.
2
CHAT gene polymorphism rs3810950 is associated with the risk of Alzheimer's disease in the Czech population.CHAT 基因多态性 rs3810950 与捷克人群阿尔茨海默病的风险相关。
J Biomed Sci. 2018 May 14;25(1):41. doi: 10.1186/s12929-018-0444-2.
3
Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease.
重新审视迈内特基底核:解剖学、历史及在阿尔茨海默病和帕金森病中的不同受累情况
Acta Neuropathol. 2015 Apr;129(4):527-40. doi: 10.1007/s00401-015-1392-5. Epub 2015 Jan 30.
4
Lipidomics of Alzheimer's disease: current status.阿尔茨海默病的脂质组学:现状。
Alzheimers Res Ther. 2012 Feb 1;4(1):5. doi: 10.1186/alzrt103.
5
Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease.醚脂类脑苷脂前体 PPI-1011 的口服生物利用度在兔体内:阿尔茨海默病的一种新治疗策略。
Lipids Health Dis. 2011 Dec 5;10:227. doi: 10.1186/1476-511X-10-227.
6
Reduction of neuronal intranuclear rodlets immunoreactive for tubulin and glucocorticoid receptor in Alzheimer's disease.阿尔茨海默病中对微管蛋白和糖皮质激素受体免疫反应性的神经元核内小杆减少。
Brain Pathol. 2002 Jul;12(3):300-7. doi: 10.1111/j.1750-3639.2002.tb00444.x.
7
Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice.在Tg2576小鼠进行性中枢神经系统淀粉样蛋白生成过程中稳定的β-分泌酶活性和突触前胆碱能标志物
Am J Pathol. 2002 Feb;160(2):731-8. doi: 10.1016/s0002-9440(10)64893-6.
8
The cholinergic neuronal phenotype in Alzheimer's disease.阿尔茨海默病中的胆碱能神经元表型。
Metab Brain Dis. 2000 Mar;15(1):45-64. doi: 10.1007/BF02680013.
9
Transgenic mouse models of Alzheimer's disease and amyotrophic lateral sclerosis.阿尔茨海默病和肌萎缩侧索硬化症的转基因小鼠模型。
Brain Pathol. 1998 Oct;8(4):735-57. doi: 10.1111/j.1750-3639.1998.tb00198.x.
10
The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations.人脑无名质及相邻区域:组织化学与生物化学观察
J Anat. 1984 Jun;138 ( Pt 4)(Pt 4):713-32.